263 related articles for article (PubMed ID: 33500295)
1. Pneumococcal induced thrombotic thrombocytopenic purpura with features of purpura fulminans.
Walsh LF; Sherbuk JE; Wispelwey B
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33500295
[TBL] [Abstract][Full Text] [Related]
2. Septic Shock and Purpura Fulminans Due to Streptococcus pneumoniae Bacteremia in an Unvaccinated Immunocompetent Adult: Case Report and Review.
Djurdjevic N; Taweesedt PT; Paulson M; LaNou A; Radovanovic M; Patel JN; Veselinovic M; McDermott WR; Dumic I
Am J Case Rep; 2020 Jun; 21():e923266. PubMed ID: 32513908
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal sepsis-induced purpura fulminans in an asplenic adult patient without disseminated intravascular coagulation.
Saraceni C; Schwed-Lustgarten D
Am J Med Sci; 2013 Dec; 346(6):514-6. PubMed ID: 24185261
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic Thrombocytopenic Purpura: Beyond Empiricism and Plasma Exchange.
Tsai HM
Am J Med; 2019 Sep; 132(9):1032-1037. PubMed ID: 30928346
[TBL] [Abstract][Full Text] [Related]
5. A case of thrombotic thrombocytopenic purpura associated with COVID-19.
Nicolotti D; Bignami EG; Rossi S; Vezzani A
J Thromb Thrombolysis; 2021 Aug; 52(2):468-470. PubMed ID: 33389519
[TBL] [Abstract][Full Text] [Related]
6. Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.
Al-Husban N; Al-Kuran O
J Med Case Rep; 2018 Jun; 12(1):147. PubMed ID: 29855343
[TBL] [Abstract][Full Text] [Related]
7. Refractory acquired thrombotic thrombocytopenic purpura in a patient with sickle cell trait successfully treated with caplacizumab.
Aggarwal V; Singer Z; Ledingham D; Othman I
Hematology; 2021 Dec; 26(1):590-593. PubMed ID: 34396933
[No Abstract] [Full Text] [Related]
8. Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura.
Chander DP; Loch MM; Cataland SR; George JN
N Engl J Med; 2019 Jul; 381(1):92-94. PubMed ID: 31269374
[No Abstract] [Full Text] [Related]
9. Purpura Fulminans: A rare presentation of
Teo HG; Wong JY; Ting TLL
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 29054893
[TBL] [Abstract][Full Text] [Related]
10. Purpura fulminans caused by meningococcemia in an infant.
Abbas A; Mujeeb AA
BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23921694
[No Abstract] [Full Text] [Related]
11. Purpura fulminans due to
Perinkulam Sathyanarayanan S; Ahmed M; Hericks A
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35589268
[TBL] [Abstract][Full Text] [Related]
12. Successful use of a second course of caplacizumab in relapsed thrombotic thrombocytopenic purpura.
Shaffer J; Grove A
Platelets; 2022 Jul; 33(5):790-791. PubMed ID: 34565299
[TBL] [Abstract][Full Text] [Related]
13. Infectious purpura fulminans associated with pneumococcal septicaemia in a patient with unacknowledged functional asplenia.
Duus S; Jespersen S; Wejse C
BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38531552
[TBL] [Abstract][Full Text] [Related]
14. Streptococcus pneumoniae-induced purpura fulminans in a woman with functional asplenia.
Wojtowicz JM; Longden Jones G
CJEM; 2014 Jul; 16(4):339-42. PubMed ID: 25060091
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura.
Goshua G; Sinha P; Hendrickson JE; Tormey C; Bendapudi PK; Lee AI
Blood; 2021 Feb; 137(7):969-976. PubMed ID: 33280030
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic plasma exchange in thrombotic thrombocytopenic purpura.
Picod A; Provôt F; Coppo P
Presse Med; 2019 Nov; 48(11 Pt 2):319-327. PubMed ID: 31759790
[TBL] [Abstract][Full Text] [Related]
17. Caplacizumab: an anti-von Willebrand factor antibody for the treatment of thrombotic thrombocytopenic purpura.
Hollifield AL; Arnall JR; Moore DC
Am J Health Syst Pharm; 2020 Jul; 77(15):1201-1207. PubMed ID: 32588878
[TBL] [Abstract][Full Text] [Related]
18. Current and Future Perspectives on ADAMTS13 and Thrombotic Thrombocytopenic Purpura.
Roose E; Joly BS
Hamostaseologie; 2020 Aug; 40(3):322-336. PubMed ID: 32726827
[TBL] [Abstract][Full Text] [Related]
19. Severe primary refractory thrombotic thrombocytopenic purpura (TTP) in the post plasma exchange (PEX) and rituximab era.
Goranta S; Deliwala SS; Haykal T; Bachuwa G
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32532908
[TBL] [Abstract][Full Text] [Related]
20. Successful use of caplacizumab in a case of refractory acquired thrombotic thrombocytopenic purpura following subacute thyroiditis.
Loscocco GG; Malandrino D; Vannini F; Vinci MC; Di Marzio G; Fallai L; Scappini B
Transfus Apher Sci; 2021 Feb; 60(1):103010. PubMed ID: 33223471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
